A Phase 1/2 Dose-Escalation Study of the Safety, Efficacy and Pharmacokinetics of Glufosfamide in Combination With Gemcitabine in Advanced Solid Tumors and Pancreatic Adenocarcinoma.
Phase of Trial: Phase I/II
Latest Information Update: 12 May 2009
At a glance
- Drugs Gemcitabine; Glufosfamide
- Indications Pancreatic cancer; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- Sponsors Threshold Pharmaceuticals
- 07 Jun 2017 Biomarkers information updated
- 12 May 2009 Additional lead trial centre added as reported by ClinicalTrials.gov.
- 12 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.